Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Today marks 2 weeks (or longer)

<< Previous

Bullboard Posts

Next >>

Comment by Paradise818on Oct 18, 2024 10:51pm

173 Views

Post# 36272763

RE:RE:RE:RE:Today marks 2 weeks (or longer)

With all the recent failures in cancer treatments, Theralase's Rudivar is looking better and better as a safer and more effective treatment for many types of cancers. All we need is a catalyst which would be BTD and AA and it's off the races. Maybe we get bought out for 21 Billion. I'll take 5 Billion. LOL.

<< Previous

Bullboard Posts

Next >>

Apolo IV Acquisition and Marviken Ontario sign merger agreement